Axonics Statistics
Total Valuation
Axonics has a market cap or net worth of $3.45 billion. The enterprise value is $3.14 billion.
| Market Cap | 3.45B |
| Enterprise Value | 3.14B |
Important Dates
The next estimated earnings date is Monday, July 29, 2024, after market close.
| Earnings Date | Jul 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Axonics has 51.02 million shares outstanding. The number of shares has increased by 4.84% in one year.
| Shares Outstanding | 51.02M |
| Shares Change (YoY) | +4.84% |
| Shares Change (QoQ) | +3.08% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 86.34% |
| Float | 50.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 193.78 |
| PS Ratio | 8.92 |
| Forward PS | 7.24 |
| PB Ratio | 5.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.96, with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.96 |
| Quick Ratio | 8.25 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.60% and return on invested capital (ROIC) is -4.69%.
| Return on Equity (ROE) | -2.60% |
| Return on Assets (ROA) | -2.30% |
| Return on Capital (ROIC) | -4.69% |
| Revenue Per Employee | $485,744 |
| Profits Per Employee | -$20,015 |
| Employee Count | 797 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, Axonics has paid $2.00 million in taxes.
| Income Tax | 2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.60% in the last 52 weeks. The beta is 0.83, so Axonics's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +31.60% |
| 50-Day Moving Average | 67.42 |
| 200-Day Moving Average | 63.87 |
| Relative Strength Index (RSI) | 53.56 |
| Average Volume (20 Days) | 341,463 |
Short Selling Information
The latest short interest is 3.40 million, so 6.66% of the outstanding shares have been sold short.
| Short Interest | 3.40M |
| Short Previous Month | 3.38M |
| Short % of Shares Out | 6.66% |
| Short % of Float | 6.74% |
| Short Ratio (days to cover) | 9.18 |
Income Statement
In the last 12 months, Axonics had revenue of $387.14 million and -$15.95 million in losses. Loss per share was -$0.31.
| Revenue | 387.14M |
| Gross Profit | 291.31M |
| Operating Income | -30.87M |
| Pretax Income | -13.95M |
| Net Income | -15.95M |
| EBITDA | -1.10M |
| EBIT | -13.95M |
| Loss Per Share | -$0.31 |
Balance Sheet
The company has $348.63 million in cash and $31.61 million in debt, giving a net cash position of $317.02 million or $6.21 per share.
| Cash & Cash Equivalents | 348.63M |
| Total Debt | 31.61M |
| Net Cash | 317.02M |
| Net Cash Per Share | $6.21 |
| Equity (Book Value) | 627.10M |
| Book Value Per Share | 12.29 |
| Working Capital | 433.64M |
Cash Flow
In the last 12 months, operating cash flow was -$10.47 million and capital expenditures -$5.82 million, giving a free cash flow of -$16.29 million.
| Operating Cash Flow | -10.47M |
| Capital Expenditures | -5.82M |
| Free Cash Flow | -16.29M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 75.25%, with operating and profit margins of -7.97% and -4.12%.
| Gross Margin | 75.25% |
| Operating Margin | -7.97% |
| Pretax Margin | -3.60% |
| Profit Margin | -4.12% |
| EBITDA Margin | -0.28% |
| EBIT Margin | -3.60% |
| FCF Margin | -4.21% |
Dividends & Yields
Axonics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.84% |
| Shareholder Yield | -4.84% |
| Earnings Yield | -0.46% |
| FCF Yield | -0.47% |
Analyst Forecast
The average price target for Axonics is $70.71, which is 4.42% higher than the current price. The consensus rating is "Hold".
| Price Target | $70.71 |
| Price Target Difference | 4.42% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 19.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axonics has an Altman Z-Score of 23.86 and a Piotroski F-Score of 4.
| Altman Z-Score | 23.86 |
| Piotroski F-Score | 4 |